Planned phase I trial to investigate the tolerability of APF 580 for the treatment of pain.
Phase of Trial: Phase I
Latest Information Update: 15 May 2008
At a glance
- Drugs APF 580 (Primary)
- Indications Pain
- Focus Adverse reactions
- 15 May 2008 A.P. Pharma expects to initiate the trial in the 2nd quarter of 2008.
- 03 Dec 2007 New trial record.
- 14 Nov 2007 Plan to initiate phase I trial in first half of 2008.